Contraceptive counselling for females with heart disease requires individualized assessment, as no studies have investigated the relative risks of different methods in this population.
Contraceptive counselling for females with heart disease requires individualized, multidisciplinary assessment, though no specific studies exist on the relative risks and benefits of different methods in this population.
Contraceptive counselling should begin early in females with heart disease, preferably directly after the start of menstruation. In coming to a decision about the method of contraception, the following issues should be considered: (i) the risk of pregnancy for the mother and the consequences of an unplanned pregnancy; (ii) the risks of the contraceptive method; (iii) failure rates; (iv) the non-contraceptive benefits; (v) the availability; (vi) the individual's preferences; (vii) protection against infection; and (viii) costs. In some women with heart disease, the issues may be complex and require the input of both a cardiologist and an obstetrician (or other feto-maternal expert) to identify the optimal approach. No studies have been performed in women with heart disease to investigate the relative risks and benefits of different contraceptive methods.
Roos‐Hesselink et al. (Wed,) conducted a review in Heart disease. Contraception was evaluated. Contraceptive counselling for females with heart disease requires individualized assessment, as no studies have investigated the relative risks of different methods in this population.